Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
Authors
Keywords
-
Journal
BMJ Open
Volume 11, Issue 10, Pages e055611
Publisher
BMJ
Online
2021-10-12
DOI
10.1136/bmjopen-2021-055611
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody response to mRNA SARS-CoV-2 vaccine among kidney transplant recipients – Prospective cohort study
- (2021) Benaya Rozen-Zvi et al. CLINICAL MICROBIOLOGY AND INFECTION
- Early antibody response in healthcare professionals after two doses of SARS-CoV-2 mRNA vaccine (BNT162b2)
- (2021) Julien Favresse et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients – a prospective cohort study
- (2021) Osnat Itzhaki Ben Zadok et al. EUROPEAN JOURNAL OF HEART FAILURE
- Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients
- (2021) Liane Rabinowich et al. JOURNAL OF HEPATOLOGY
- Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
- (2021) Joseph E. Ebinger et al. NATURE MEDICINE
- Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine
- (2021) Yael Shostak et al. Lancet Respiratory Medicine
- Severe consequences of COVID‐19 infection among vaccinated kidney transplant recipients
- (2021) Noam Tau et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
- (2021) Rabah Redjoul et al. LANCET
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
- (2021) Victoria G. Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular And Humoral Immune Responses after Three Doses of BNT162b2 mRNA SARS-Cov-2 Vaccine in Kidney Transplant
- (2021) Julian Stumpf et al. TRANSPLANTATION
- Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients
- (2021) Hector Rincon-Arevalo et al. Science Immunology
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunosuppression reduction in kidney transplant recipients during bacterial infection—A retrospective study
- (2019) Dafna Yahav et al. CLINICAL TRANSPLANTATION
- Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review
- (2013) Isabella Eckerle et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started